Novel mRNA Cap Structure Published in Nature Biotechnology

We are proud to announce that our collaborative research on novel cap structure engineering has been published in Nature Biotechnology. The paper, titled “Engineered Cap Analogs for Enhanced mRNA Translation and Reduced Immunogenicity,” presents our findings on a new class of cap analogs that significantly improve mRNA therapeutic performance.

This work represents a major advancement in mRNA technology and has potential applications in vaccine development, protein replacement therapy, and cancer immunotherapy.